Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer
Sign Up to like & getrecommendations! Published in 2017 at "Journal Of The National Cancer Institute"
DOI: 10.1093/jnci/djw272
Abstract: Background The prognostic value of BRAF and KRAS mutations within microsatellite-unstable (MSI) and microsatellite-stable (MSS) subgroups of resected colon carcinoma patients remains controversial. We examined this question in prospectively collected biospecimens from stage III colon… read more here.
Keywords: stage iii; braf kras; colon; cancer ... See more keywords